Humira(CF) pen 40 MG/0.4 MLS
Ended Awarded
- Contract number
- SPE2DB26FDT10
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,267
Award facts
- Contract value 100% obligated
- $50,267.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,267.26 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL dosage strength. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The $999.99 billion DLA Troop Support Medical IDC represents a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for HUMIRA, a biologic immunosuppressant used to treat various inflammatory conditions, exemplifies the types of specialty pharmaceutical products that AmerisourceBergen routinely procures through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB26FDT10?
SPE2DB26FDT10 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FDT10 worth?
The government has obligated $50,267 on SPE2DB26FDT10.
Is contract SPE2DB26FDT10 an order under another contract?
Yes. SPE2DB26FDT10 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDT10 competed?
The extent of competition for SPE2DB26FDT10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award